Feb 13, 2018
If you're looking for no-cost customized, personalized, one-on-one expert advice on all sorts of issues that people with MS encounter, you're going to want to pay attention to my conversation with Kay Julian, Executive Vice-President of Services at the National MS Society.
We're also talking about the demographic imbalance in MS
clinical trials, and why that matters. (And you can find the
Accelerated Cure Project's MS Minority Research Engagement
Report here).
We're discussing the initial results of a clinical trial of a
stem cell therapy that may reverse physical disability in
progressive MS. It may turn out that a drug designed to improve
walking for people with MS may have some additional benefits. And
we're also talking about research from Penn State that may explain
one reason why 50% of the people living with MS are going to be
diagnosed with depression.
We have a lot to talk about! So are you ready for RealTalk MS?